ACADIA Pharmaceuticals, Inc. (ACAD)

24.85 +0.26 (+1.06%) USD  |  NASDAQ  |  Feb 25, 12:07
More

ACADIA Pharmaceuticals Net Change in Capital Expenditures (Quarterly)

Net Change in Capital Expenditures (Quarterly) Chart

View Net Change in Capital Expenditures (Quarterly) for ACAD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Change in Capital Expenditures (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years

View Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Change in Capital Expenditures (Quarterly) Benchmarks

View Net Change in Capital Expenditures (Quarterly) Benchmarks
Start Trial
Marker Therapeutics, Inc. Upgrade
Dynavax Technologies Corp. (DELISTED) Upgrade
Axsome Therapeutics, Inc. Upgrade
Rhythm Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade